Preview Mode Links will not work in preview mode

GRACEcast


Apr 27, 2013

Dr. Rosalyn Juergens, McMaster University, addresses the question of whether to obtain molecular marker results in patients with early stage lung cancer and what to do with that information if it is available for potential use in the adjuvant setting.